Matches in Nanopublications for { ?s ?p "[Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_assertion description "[Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- NP362430.RAngH8J90z0bimNdzXe1Cne54TNfNJRMv3oKP6QsfMh1c130_assertion description "[Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362430.RAngH8J90z0bimNdzXe1Cne54TNfNJRMv3oKP6QsfMh1c130_provenance.
- assertion description "[Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.